AL-54478 Proof of Concept Study

NCT01318252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma (OAG)
Ocular Hypertension (OHT)

Interventions

DRUG: AL-54478 0.005%
DRUG: Latanoprost 0.005%
DRUG: AL-54478 Vehicle

Sponsor

Alcon Research